EMR vs GPC
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 06, 2026
EMR
GPC
Investment Advisor Scores
GPC
AI Analyst Insights
Detailed Metrics Comparison
| Metric | EMR | GPC | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 20.4918 | 16 | GPC |
| PEG Ratio | 1.7016 | 1.3205 | GPC |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 7.0% | 6.0% | EMR |
| Earnings Growth | 23.0% | -9.8% | EMR |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 59.8/100 | 61.1/100 | GPC |
| Profit Margin | 13.8% | 0.1% | EMR |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | BUY | HOLD | EMR |
Relative Price Performance (Last 90 Days)
Current Technical Phase
EMR
NeutralMixed signals - no dominant trend phase, RSI 49
GPC
MarkupPrice above SMA50, rising 50-day trend (11.3% over 20 days), RSI 61
Fundamentals Snapshot
| Metric | EMR | GPC |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 21.1 | 16.6 |
| Trailing P/E | 32.9 | 550.5 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.1% |
| Gross Margin | 0.5% | 0.4% |
| Operating Margin | 0.3% | 0.1% |
| EPS | 4.57 | 0.25 |
| Dividend Yield | 0.01% | 0.03% |